Headline

The latest stories from AHA Today.

HHS reminded eligible health care providers that they have until June 3 to attest to receipt of payments from the Public Health and Social Services Emergency Fund, accept the terms and conditions and submit their revenue information to potentially qualify for an additional payment from the $50…
The Health Resources and Services Administration, part of the Department of Health and Human Services, provided $225 million to rural health clinics for COVID-19 testing.
The AHA is encouraged by the Federal Emergency Management Agency’s proposal to use its authority under the Defense Production Act to establish a voluntary agreement of key private sector stakeholders to coordinate COVID-19 response and information sharing, the association told the agency.
The Centers for Medicare & Medicaid Services released early stakeholder insights from its Accountable Health Communities Model.
Hospitals can submit their stories of kindness in overcoming the COVID-19 pandemic by May 31 to be featured in Reader's Digest's Nicest Places in America 2020.
The AFL-CIO asked the U.S. Court of Appeals for the District of Columbia Circuit to order the Occupational Safety and Health Administration to issue within 30 days an emergency temporary standard to protect U.S. workers from COVID-19 under the Occupational Safety and Health Act of 1970.
In response to the significant impact of the COVID-19 pandemic on nursing homes, the Centers for Medicare & Medicaid Services recommended criteria for state and local officials who are considering how to mitigate risks.
The Small Business Administration released the application that borrowers must submit to the lender servicing their Paycheck Protection Program loan to request forgiveness for some or all of the loan.
The CDC awarded $10.25 billion from the Paycheck Protection Program and Health Care Enhancement Act to states, territories and local jurisdictions, and $750 million to tribal health programs to expand COVID-19 testing capacity and related activities.
HHS announced a $354 million agreement with a private partnership to make more active pharmaceutical ingredients and generic drugs in the United States to treat patients hospitalized with COVID-19 and prevent shortages of essential medicines.